Establishment Labs (NASDAQ:ESTA) Trading 10.1% Higher - Should You Buy?

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report)'s share price was up 10.1% on Wednesday . The company traded as high as $36.61 and last traded at $36.51. Approximately 522,421 shares traded hands during mid-day trading, a decline of 50% from the average daily volume of 1,049,284 shares. The stock had previously closed at $33.15.

Analyst Ratings Changes

A number of analysts recently issued reports on ESTA shares. Citigroup boosted their price objective on Establishment Labs from $45.00 to $50.00 and gave the company a "neutral" rating in a research note on Tuesday, October 1st. BTIG Research upped their price target on Establishment Labs from $62.00 to $65.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Finally, Stephens upgraded shares of Establishment Labs to a "strong-buy" rating in a research report on Monday, December 2nd. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Establishment Labs has a consensus rating of "Buy" and a consensus target price of $60.60.

Establishment Labs Price Performance

The business has a 50 day simple moving average of $43.75 and a two-hundred day simple moving average of $43.60. The firm has a market capitalization of $970.13 million, a P/E ratio of -13.43 and a beta of 1.15. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Institutional Trading of Establishment Labs

Hedge funds have recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Establishment Labs by 1.8% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company's stock valued at $1,525,000 after buying an additional 632 shares in the last quarter. Hood River Capital Management LLC bought a new position in shares of Establishment Labs during the 2nd quarter valued at $43,000. Verition Fund Management LLC lifted its stake in Establishment Labs by 22.8% in the third quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock worth $407,000 after purchasing an additional 1,746 shares during the last quarter. HighTower Advisors LLC boosted its position in Establishment Labs by 32.5% during the third quarter. HighTower Advisors LLC now owns 10,311 shares of the company's stock valued at $446,000 after buying an additional 2,529 shares during the period. Finally, SkyView Investment Advisors LLC boosted its position in Establishment Labs by 30.5% during the third quarter. SkyView Investment Advisors LLC now owns 12,000 shares of the company's stock valued at $519,000 after buying an additional 2,805 shares during the period. 72.91% of the stock is owned by institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.